US › Healthcare

MediciNova Inc (MNOV)

US · Healthcare · Biotechnology

$1.30-2.26%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$186,984
Net profit
$-2.6M
Profit YoY
+9.7%
EPS
$-0.05
EPS estimate
$-0.06
Net margin
-1,383.1%

EPS came in at -0.05 against a street estimate of -0.06 — a beat of 16.7%.

Key statistics

Market cap
$65.5M
Forward P/E
8.5
P/B
1.66
Book value
$0.80
EPS (TTM)
$-0.23
52-week high
$1.96
52-week low
$1.17
50-day MA
$1.34
200-day MA
$1.42
Beta
0.62

Analyst view

Analysts rate MediciNova Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $9.00.

Shareholding

Insiders
2.88%
Institutions
11.05%

Largest institutional holders

FundStake
Essex Woodlands Health Ventures2.25%
BlackRock Inc1.43%
Vanguard Group Inc1.43%
Citigroup Inc1.29%
Vanguard Capital Management, LLC1.24%
Geode Capital Management, LLC1.10%
Vanguard Fiduciary Trust Co0.57%
UBS Group AG0.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for MediciNova Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.